Histone methyltransferase: Difference between revisions

Michal Harel (talk | contribs)
New page: '''Histone methyltransferase''' (HMT) are histone-lysine N-methyltransferase (KHMT) and histone-arginine N-methyltransferase (RHMT) which catalyzes the transfer of methyl groups to ly...
 
Michal Harel (talk | contribs)
No edit summary
 
(37 intermediate revisions by 3 users not shown)
Line 1: Line 1:
<StructureSection load='' size='350' side='right' caption='Human histone-lysine N-methyltrasferase (magenta) complex with methylated lysine histone H3 peptide (green) and S-adenosyl homocysteine (SAH) (PDB entry [[1o9s]])' scene='46/467278/Cv/1'>


== Function ==
'''Histone methyltransferase''' (HMT) are '''histone-lysine N-methyltransferase''' (KHMT)  and '''histone-arginine N-methyltransferase''' (RHMT)  which catalyzes the transfer of methyl groups to lysine and arginine residues of histones<ref>PMID:15248813</ref>.  HMT use S-adenosyl methionine (SAM) or S-adenosyl homocysteine (SAH) as the methyl donor.  KHMT can be SET domain-containing or non-SET domain-containing.  The SET domain contains the catalytic core of KHMT and targets the lysine tail region of KHMT.  CxxC domain is a zinc finger domain.


For SET7/9 see [[Histone Lysine Methyltransferase SET7/9]].


'''Histone methyltransferase''' (HMT) are histone-lysine N-methyltransferase (KHMT)  and histone-arginine N-methyltransferase (RHMT)  which catalyzes the transfer of methyl groups to lysine and arginine residues of histones.  HMT use S-adenosyl methionine (SAM) or S-adenosyl homocysteine (SAH) as the methyl donor.
*'''euchromatin histone methyltransferase''' dimethylates histone H3 at Lys 9 resulting in transcriptional repression<ref>PMID:32684241</ref>.
*'''DOT1L histone methyltransferase''' methylates histone H3 at Lys 79 resulting in transcriptional repression<ref>PMID:35495127</ref>.


[[1nw3]] – hHMT DOT1L – human
== Relevance ==
Inhibitors of the histone-lysine N-methyltransferase SMYD2 which represses the tumor-suppressing activities of p53 are studied as cancer therapy drugs<ref>PMID:21782458</ref>.


[[2igq]] – hHMT-1 C terminal
== Disease ==
Aberrant HMT plays a role in cancer, intellectual disability syndromes and regulation of tissue aging<ref>PMID:22473383</ref>.


===Histone-lysine N-methyltransferase===
== Structural highlights ==
Human <scene name='46/467278/Cv/6'>KHMT binds SAH in the peptide binding groove with the histone H3 peptide assuming an extended conformation and the methylated lysine</scene> inserted in a hydrophobic environment<ref>PMID:12540855</ref>. Water molecules shown as red spheres


[[2j8a]] – KHMT SET1 RRM domain – yeast
== 3D Structures of histone methyltransferase ==
[[Histone methyltransferase 3D structures]]


[[3s8s]] – hKHMT SETD1A RRM domain
</StructureSection>


[[3rib]] – hKHMT Smyd2 + SAH
== References ==
 
<references/>
[[3s7b]] - hKHMT Smyd2 + SAM + inhibitor
[[Category:Topic Page]]
 
[[3s7d]], [[3s7f]], [[3tg5]] - hKHMT Smyd2 + SAH + p53 peptide
 
[[3s7j]], [[3tg4]] - hKHMT Smyd2 + SAM

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Joel L. Sussman